Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study
PaperCitations, authors & open-access status
Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 451 citations, 2021 year and green oa status.
451
Citations
2021
Year
green
OA Status